Miracle Light Venture(MLV) focuses on the early-stage projects with high growth potential in life science industry. Up to 2019, MLV has invested about 20 life science startups, with total value over 100 million RMB, promoted the tech-transfer of a group of innovative startups with frontier technologies.
Focus on early project investment in life sciences
Artificial intelligence + medical, mass spectrometry testing services, drug research and development applications, scientific research sequencing services, other CRO services, biological information
Upstream
Molecular diagnostic equipment, biochemical, immunodiagnostic equipment, POCT one machine, mass spectrometry, synthetic biology
verification
platform
investment
Advantage
Brand
endorsement
After casting
value
reserve
project
project
source
management
team
Exclusive project source
Posses exclusive project source, including BGI Research, BGI’s domestic and international BU, BGI Accelerator and a group of local industrial partners.
Outstanding management team
Management and counsel team have solid background, rich experience, deep understanding and tech-accumulation in life science and healthcare industry.
High-quality project pool
Have plenty high-quality candidates in project pool.
First-class validation platform
BGI brand
Multiple post-investment value
With the help of BGI Research, MGI, National GeneBank, sequencing, storage, computation, R&D and other resources are available to facilitate the validation and valuation of the technology, and assist the estimate of the investment.
Assign multiple post-investment value to startups based on BGI’s superior tech-transfer experience, technology accumulation, R&D ability, business network and BD ability
Obtain endorsement from BGI’s brand and reputation, which is the world’s largest genomics research institution.
